The global breast cancer diagnostics market size is calculated at USD 20.14 billion in 2025 and is forecasted to reach around USD 40.71 billion by 2034, accelerating at a CAGR of 8.13% from 2025 to 2034. The North America breast cancer diagnostics market size surpassed USD 8.53 billion in 2024 and is expanding at a CAGR of 8.14% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Breast Cancer Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Breast Cancer Diagnostics Market, by Product Type,
8.1.1. Platform-based Products
8.1.1.1. Market Revenue and Forecast
8.1.2. Instrument-based Products
8.1.2.1. Market Revenue and Forecast
9.1. Breast Cancer Diagnostics Market, by Type,
9.1.1. Imaging
9.1.1.1. Market Revenue and Forecast
9.1.2. Biopsy
9.1.2.1. Market Revenue and Forecast
9.1.3. Genomic Tests
9.1.3.1. Market Revenue and Forecast
9.1.4. Blood Tests
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. Breast Cancer Diagnostics Market, by Application Type,
10.1.1. Screening
10.1.1.1. Market Revenue and Forecast
10.1.2. Diagnostic and Predictive
10.1.2.1. Market Revenue and Forecast
10.1.3. Prognostic
10.1.3.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast
11.1. Breast Cancer Diagnostics Market, by End Use Type,
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast
11.1.2. Diagnostic Centers & Medical Laboratories
11.1.2.1. Market Revenue and Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product
12.1.2. Market Revenue and Forecast, by Type
12.1.3. Market Revenue and Forecast, by Application Type
12.1.4. Market Revenue and Forecast, by End Use Type
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product
12.1.5.2. Market Revenue and Forecast, by Type
12.1.5.3. Market Revenue and Forecast, by Application Type
12.1.5.4. Market Revenue and Forecast, by End Use Type
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product
12.1.6.2. Market Revenue and Forecast, by Type
12.1.6.3. Market Revenue and Forecast, by Application Type
12.1.6.4. Market Revenue and Forecast, by End Use Type
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product
12.2.2. Market Revenue and Forecast, by Type
12.2.3. Market Revenue and Forecast, by Application Type
12.2.4. Market Revenue and Forecast, by End Use Type
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product
12.2.5.2. Market Revenue and Forecast, by Type
12.2.5.3. Market Revenue and Forecast, by Application Type
12.2.5.4. Market Revenue and Forecast, by End Use Type
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product
12.2.6.2. Market Revenue and Forecast, by Type
12.2.6.3. Market Revenue and Forecast, by Application Type
12.2.6.4. Market Revenue and Forecast, by End Use Type
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product
12.2.7.2. Market Revenue and Forecast, by Type
12.2.7.3. Market Revenue and Forecast, by Application Type
12.2.7.4. Market Revenue and Forecast, by End Use Type
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product
12.2.8.2. Market Revenue and Forecast, by Type
12.2.8.3. Market Revenue and Forecast, by Application Type
12.2.8.4. Market Revenue and Forecast, by End Use Type
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product
12.3.2. Market Revenue and Forecast, by Type
12.3.3. Market Revenue and Forecast, by Application Type
12.3.4. Market Revenue and Forecast, by End Use Type
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product
12.3.5.2. Market Revenue and Forecast, by Type
12.3.5.3. Market Revenue and Forecast, by Application Type
12.3.5.4. Market Revenue and Forecast, by End Use Type
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product
12.3.6.2. Market Revenue and Forecast, by Type
12.3.6.3. Market Revenue and Forecast, by Application Type
12.3.6.4. Market Revenue and Forecast, by End Use Type
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product
12.3.7.2. Market Revenue and Forecast, by Type
12.3.7.3. Market Revenue and Forecast, by Application Type
12.3.7.4. Market Revenue and Forecast, by End Use Type
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product
12.3.8.2. Market Revenue and Forecast, by Type
12.3.8.3. Market Revenue and Forecast, by Application Type
12.3.8.4. Market Revenue and Forecast, by End Use Type
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product
12.4.2. Market Revenue and Forecast, by Type
12.4.3. Market Revenue and Forecast, by Application Type
12.4.4. Market Revenue and Forecast, by End Use Type
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product
12.4.5.2. Market Revenue and Forecast, by Type
12.4.5.3. Market Revenue and Forecast, by Application Type
12.4.5.4. Market Revenue and Forecast, by End Use Type
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product
12.4.6.2. Market Revenue and Forecast, by Type
12.4.6.3. Market Revenue and Forecast, by Application Type
12.4.6.4. Market Revenue and Forecast, by End Use Type
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product
12.4.7.2. Market Revenue and Forecast, by Type
12.4.7.3. Market Revenue and Forecast, by Application Type
12.4.7.4. Market Revenue and Forecast, by End Use Type
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product
12.4.8.2. Market Revenue and Forecast, by Type
12.4.8.3. Market Revenue and Forecast, by Application Type
12.4.8.4. Market Revenue and Forecast, by End Use Type
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product
12.5.2. Market Revenue and Forecast, by Type
12.5.3. Market Revenue and Forecast, by Application Type
12.5.4. Market Revenue and Forecast, by End Use Type
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product
12.5.5.2. Market Revenue and Forecast, by Type
12.5.5.3. Market Revenue and Forecast, by Application Type
12.5.5.4. Market Revenue and Forecast, by End Use Type
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product
12.5.6.2. Market Revenue and Forecast, by Type
12.5.6.3. Market Revenue and Forecast, by Application Type
12.5.6.4. Market Revenue and Forecast, by End Use Type
13.1. Genomic Health
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. NanoString Technologies Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Paragon Biosciences LLC
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Devicor Medical Products Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. AstraZeneca
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Quest Diagnostics Incorporated
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Koninklijke Philips N.V.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Siemens AG
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Biocept Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Epigenomics Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample